INTOMEDI FIRST AMPOULE PLACENTA- adenosine liquid

INTOMEDI FIRST AMPOULE PLACENTA by

Drug Labeling and Warnings

INTOMEDI FIRST AMPOULE PLACENTA by is a Otc medication manufactured, distributed, or labeled by Janytree Inc.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

INACTIVE INGREDIENTS

Water, Hydrolyzed Horse Placenta Extract(150,000ppm), Ethyl Ascorbyl Ether, Dipropylene
Glycol, Lactobacillus/Hydrolyzed Pea Seed Extract Ferment Filtrate(Bio-Peptone®),
1,2-Hexanediol, Glycerin, Butylene Glycol, Dimethyl Sulfone, Centella Asiatica Extract,
Dexpanthenol, Pentylene Glycol, Mentha Piperita (Peppermint) Extract, Allantoin,
Sodium Hyaluronate, Hydrolyzed Collagen, Scutellaria Baicalensis Root Extract, Polygonum
Cuspidatum Root Extract, Glycyrrhiza Glabra (Licorice) Root Extract, Portulaca Oleracea Extract,
Camellia Sinensis Leaf Extract, Sodium Hyaluronate Crosspolymer, Rosmarinus Officinalis
(Rosemary) Leaf Extract, Chamomilla Recutita (Matricaria) Flower Extract, Copper Tripeptide-1

ACTIVE INGREDIENTS

adenosine

PURPOSE

A highly concentrated ampoule for healthy pores and soft skin texture.
Formulated with plenty of Hydrolyzed Horse Placenta Extract, Adenosine, CTP-1

WARNINGS

For external use only When using this product
■ If following abnormal symptoms occurs after using the product, stop using the product and consult with a skin specialist. Symptoms : Red specks, swelling, itching
■ Do not use on the skin parts affected by wound, eczema, or dermatitis.
Keep out of reach of children.
■ If swallowed, get a medical help or contact a person in control center immediately.
■ Avoid contact with eyes.

KEEP OUT OF REACH OF CHILDREN

KEEP OUT OF REACH OF CHILDREN

If swallowed, get a medical help or contact a person in control center immediately.

INDICATIONS & USAGE

apply a proper amount to the skin, and massage gently until fully absorbed

DOSAGE & ADMINISTRATION

for external use only

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

INTOMEDI FIRST AMPOULE PLACENTA 
adenosine liquid

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 82879-0005
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
ADENOSINE (UNII: K72T3FS567) (ADENOSINE - UNII:K72T3FS567)	ADENOSINE	0.1 g  in 100 mL

Inactive Ingredients
Ingredient Name	Strength
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)
WATER (UNII: 059QF0KO0R)
GLYCERIN (UNII: PDC6A3C0OX)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 82879-0005-2	5 in 1 PACKAGE	07/13/2022
1	NDC: 82879-0005-1	5 mL in 1 BOTTLE; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
unapproved drug other		07/13/2022

Labeler - Janytree Inc. (688403840)

Registrant - Janytree Inc. (688403840)

Establishment
Name	Address	ID/FEI	Business Operations
Janytree Inc.		688403840	manufacture(82879-0005)